Beta-blockers, lipoproteins and non-insulin dependent diabetes

Postgrad Med J. 1988 Dec;64(758):926-30. doi: 10.1136/pgmj.64.758.926.

Abstract

In a study on 138 hypertensive non-insulin dependent diabetic subjects, factors influencing lipoproteins were assessed. Multiple regression analyses were carried out in order to assess the influence of beta-blocker antihypertensive therapy while making allowances for other confounding variables. In males, but not in females, on a beta-blocker for hypertension, total high density lipoprotein- (HDL-) and HDL-subfraction cholesterol were significantly lower while the serum triglyceride was increased, though not significantly. In male non-insulin dependent diabetics, regimens containing a beta-blocker may worsen an already abnormal lipoprotein profile and antihypertensive agents other than beta-blocking agents should be used if possible.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Cholesterol, HDL / blood
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Female
  • Humans
  • Hypertension / blood
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Lipoproteins / blood*
  • Lipoproteins, HDL / blood
  • Male
  • Middle Aged
  • Regression Analysis

Substances

  • Adrenergic beta-Antagonists
  • Cholesterol, HDL
  • Lipoproteins
  • Lipoproteins, HDL